Related Experiment Videos
DFNA9 is a progressive audiovestibular dysfunction with a microfibrillar deposit in the inner ear
1Massachusetts Eye and Ear Infirmary and Brigham and Women's Hospital, Boston, USA.
The Laryngoscope
|August 15, 2000
Summary
Mutations in the COCH gene cause progressive hearing loss and vestibular dysfunction in DFNA9 patients. Electron microscopy revealed unique deposits in the inner ear, suggesting a novel disease mechanism.
Area of Science:
- Genetics
- Otolaryngology
- Pathology
Background:
- DFNA9 is an autosomal dominant progressive sensorineural hearing loss linked to COCH gene mutations.
- Previous studies identified COCH mutations in American and European families and suggested vestibular dysfunction.
Purpose of the Study:
- To investigate vestibular abnormalities in an American family with DFNA9 for genotype-phenotype correlation.
- To examine the ultrastructure of unique acidophilic deposits in DFNA9 patients to understand disease pathogenesis.
Main Methods:
- Prospective analysis involving extensive vestibular testing in affected and unaffected family members.
- Electron microscopy of a temporal bone from a DFNA9 patient to analyze inner ear structures.
Main Results:
- Progressive vestibular dysfunction was observed in many DFNA9 patients with hearing loss.
- Electron microscopy revealed a unique microfibrillar substance with glycosaminoglycan granules in the spiral ligament.
- DFNA9 temporal bones lacked normal type II collagen bundles in the spiral ligament.
Conclusions:
- COCH gene mutations lead to both auditory and vestibular dysfunction in DFNA9, regardless of specific mutation.
- The observed deposits and collagen abnormalities suggest a novel pathogenetic mechanism for DFNA9.
- Further research is needed to explore the relationship between DFNA9 and other audiovestibular disorders.